Based on the Direxion Daily S&P Biotech Bear 3X Shares stock forecast from 0 analysts, the average analyst target price for Direxion Daily S&P Biotech Bear 3X Shares is not available over the next 12 months. Direxion Daily S&P Biotech Bear 3X Shares’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Direxion Daily S&P Biotech Bear 3X Shares is Very Bearish, which is based on 0 positive signals and 4 negative signals. At the last closing, Direxion Daily S&P Biotech Bear 3X Shares’s stock price was USD 7.63. Direxion Daily S&P Biotech Bear 3X Shares’s stock price has changed by +1.06% over the past week, +24.07% over the past month and +18.48% over the last year.
No recent analyst target price found for Direxion Daily S&P Biotech Bear 3X Shares
No recent average analyst rating found for Direxion Daily S&P Biotech Bear 3X Shares
Company Overview Direxion Daily S&P Biotech Bear 3X Shares
The fund, under normal circumstances, invests at least 80% of the fund"s net assets in financial instruments, including swap agreements, futures contracts, or short positions, that, in combination, provide 3X daily inverse (opposite) or short exposure to the index or to ETFs that track the index, consistent with the fund"s investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the GICS. The fund is non-diversified. Read Less
The fund, under normal circumstances, invests at least 80% of the fund"s net assets in financial instruments, including swap agreements, futures contracts, or short positions, that, in combination, provide 3X daily inverse (opposite) or short exposure to the index or to ETFs that...Read More
Stock Target Advisor's fundamental analysis for Direxion Daily S&P Biotech Bear 3X Shares's stock is Very Bearish.
LABD stock's dividend yield is 5.16%.
Our analysis grades LABD stock's dividend yield at F. This means that LABD stock's dividend yield is above 21% of the stocks in the Trading--Inverse Equity sector in the NYE exchange.
Based on this LABD may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on LABD's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on LABD's stock to indicate if its overvalued.
The last closing price of LABD's stock was USD 7.63.
The most recent market capitalization for LABD is USD 0.06B.
Unfortunately we do not have enough analyst data on LABD's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Direxion Daily S&P Biotech Bear 3X Shares's stock.
Sorry, we do not have any data on the number of employees for Direxion Daily S&P Biotech Bear 3X Shares.
Sorry we do not have any infomation available on Direxion Daily S&P Biotech Bear 3X Shares's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Stock Target Advisor's fundamental analysis for Direxion Daily S&P Biotech Bear 3X Shares's stock is Very Bearish.
LABD stock's dividend yield is 5.16%.
Our analysis grades LABD stock's dividend yield at F. This means that LABD stock's dividend yield is above 21% of the stocks in the Trading--Inverse Equity sector in the NYE exchange.
Based on this LABD may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on LABD's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on LABD's stock to indicate if its overvalued.
The last closing price of LABD's stock was USD 7.63.
The most recent market capitalization for LABD is USD 0.06B.
Unfortunately we do not have enough analyst data on LABD's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Direxion Daily S&P Biotech Bear 3X Shares's stock.
Sorry, we do not have any data on the number of employees for Direxion Daily S&P Biotech Bear 3X Shares.
Sorry we do not have any infomation available on Direxion Daily S&P Biotech Bear 3X Shares's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for LABD !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
